Betahistine Dihydrochloride 8 mg,Nasal Decongestant Adult Xylometazolin HCL 0 point 1 percent bott
Indian Army
JODHPUR, RAJASTHAN
Bid Publish Date
30-Dec-2025, 9:05 am
Bid End Date
20-Jan-2026, 10:00 am
Value
₹1,10,352
Location
Progress
Quantity
27275
Category
Cinnarizine 25 mg Tab
Bid Type
Two Packet Bid
The Indian Army, Department Of Military Affairs, invites bids for a diverse range of medicinal consumables and related products, including Cinnarizine 25 mg tablet, Betahistine 8 mg tablet, Ketorolac Tromethamine 0.4% eye drops, Xylometazoline nasal drops and solutions, Sulphamethoxazole/Trimethoprim tablets, Gentamicin injections, Amoxicillin suspension, Atropine sulfate injections, Diclofenac injections, Chlorhexidine solutions, and Cetrimide products. Estimated contract value is around ₹11,035,210. The procurement targets a compliant BBQR-enabled supply chain spanning indigenous and foreign products, with a strong emphasis on shelf-life integrity and stock replacement policies. The tender emphasizes adherence to BBQR specifications, OEM authorizations, and comprehensive documentation, with a withdrawal-left delivery framework and potential quantity variation up to 50%. The bidder must upload a brochure and ensure technical alignment with BBQR requirements to avoid rejection. The tender requires participation through GeM, with a Kolkata-based technical evaluation address and a 3-month stock replacement window for near-expiry items. The opportunity is location-specific to Kolkata, and the supplier selection hinges on BBQR compliance and past performance.
Product names and categories extracted from tender: Cinnarizine 25 mg tab, Betahistine 8 mg tab, Ketorolac Tromethamine 0.4% eye drops, Xylometazoline HCl 0.1% nasal drops, Xylometazoline HCl 0.05% nasal solution for paed use, Sulphamethoxazole/Trimethoprim tablets, Gentamicin sulfate injections, Amoxicillin oral suspension (125 mg/5 ml), Atropine sulfate 0.6 mg/ml injection, Diclofenac injections, Chlorhexidine 7.5% solution with Cetrimide, etc.
- Shelf-life compliance constraints: Indigenous 5/6 remaining; Foreign 2/3 remaining at supply
- 12 total items listed in BOQ; exact quantities not disclosed
- Delivery timing aligned with last date of original delivery order
- BBQR specification adherence required for all items
50% quantity variation allowed under option clause
Delivery period starts after original order's last delivery date
BBQR compliance and OEM authorization mandatory for bid evaluation
Quantity may be increased up to 50% during contract and delivery time adjusted proportionally, with minimum 30 days extension.
Brochure and compliance with BBQR specifications must be uploaded; non-compliance risks bid rejection.
Indigenous drugs: 5/6 shelf life remaining; foreign products: 2/3 remaining at supply; CFA discretion for acceptance.
Demonstrated experience in supplying medicinal consumables and injectables
Valid OEM authorizations and annual turnover evidence
BBQR compliant documentation and capability to meet shelf-life requirements
Indian Army
JODHPUR, RAJASTHAN
Indian Air Force
JORHAT, ASSAM
Indian Army
HYDERABAD, TELANGANA
Indian Army
SRINAGAR, JAMMU & KASHMIR
Indian Army
DARJEELING, WEST BENGAL
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Cinnarizine 25 mg Tab | Cinnarizine 25 mg Tab | 2,800 | no | consignee2dglp | 30 |
| 2 | Betahistine Dihydro Chloride 8mg Tab | Betahistine Dihydro Chloride 8mg Tab | 5,505 | no | consignee2dglp | 30 |
| 3 | Ketorolac Tromethamine 0 point 4 percentage Eye Drop | Ketorolac Tromethamine 0.4% Eye Drop | 150 | bott | consignee2dglp | 30 |
| 4 | Nasal Decongestant Adult Drops Xylometazoline Hcl 0 point 1percentage W V Nasal Drop Bott of 10ml | Nasal Decongestant Adult Drops (Xylometazoline Hcl 0.1% W/V Nasal Drop) Bott of 10ml. | 1,300 | bott | consignee2dglp | 30 |
| 5 | Xylometazoline HCl 0 point 05 percentage w v nasal solution for paed use bott of 10ml | Xylometazoline HCl 0.05% w/v nasal solution for paed use bott of 10ml | 700 | bott | consignee2dglp | 30 |
| 6 | Sulphamethoxazole 400 mg and Trimethoprim 80 mg Tab | Sulphamethoxazole 400 mg & Trimethoprim 80 mg Tab | 7,500 | no | consignee2dglp | 30 |
| 7 | Gentamycin sulphate Inj IM IV 40mg ml, 2 ml Inj | Gentamycin sulphate Inj IM/IV 40mg/ml, 2 ml Inj | 2,400 | amp | consignee2dglp | 30 |
| 8 | Inj Benzathine penicillin IP 6,00,000 IU | Inj Benzathine penicillin I.P 6,00,000 I.U | 90 | amp or vial | consignee2dglp | 30 |
| 9 | Amoxycillin for oral susp containing Amoxycillin base 125mg per 5 ml after reconstitution bottle of 30 ml | Amoxycillin for oral susp containing Amoxycillin base 125mg per 5 ml after reconstitution (bottle of 30 ml) | 800 | bott | consignee2dglp | 30 |
| 10 | Atropine Sulphate 0 point6 mg, 1 ml Inj | Atropine Sulphate 0.6 mg, 1 ml Inj | 1,400 | amp | consignee2dglp | 30 |
| 11 | Diclofenac 25 mg ml IP, 3 ml Inj | Diclofenac 25 mg/ml IP, 3 ml Inj | 3,700 | amp or vial | consignee2dglp | 30 |
| 12 | Chlorhexidine Solution containing Chlorhexidine Gluconate BP 7 point 5 percentage v v Cetrimide BP 15 percentage | Chlorhexidine Solution containing Chlorhexidine Gluconate BP 7.5% v/v Cetrimide BP 15% w/v 500 ml Bott | 930 | bott | consignee2dglp | 30 |
Discover companies most likely to bid on this tender
GST registration certificate
PAN card
Experience certificates for similar medicinal supplies
Past performance/PO references
Bidder turnover statements
OEM Authorization Certificate
OEM annual turnover documents
BBQR compliance brochure and supporting documents
Technical bid documents and compliance certificates
Address and contact details for bid submission
Key insights about WEST BENGAL tender market
Bidders must submit GST registration, PAN, experience certificates, past performance data, bidder turnover, OEM authorization, OEM turnover, BBQR compliance brochure, technical bid documents, and related support documents. Ensure brochure reaches OIC GeM (Med) Kolkata before bid opening.
Upload the BBQR compliance brochure and all supporting documents; ensure items align with BBQR specifications, and provide OEM authorization certificates. Non-compliance may lead to bid rejection; verify all 12 items match BBQR schedules before submission.
Indigenous drugs must have 5/6 of shelf life remaining at supply time; foreign products must have 2/3 remaining. CFA discretion governs acceptance if shelf life is shorter than quoted, affecting supplier eligibility and delivery acceptance.
Quantity may be increased up to 50% at contract; additional delivery time is (additional/original) × original period, with a minimum of 30 days. Extension calculated from last date of extended period if option exercised.
Bid submissions occur via GeM for the Indian Army procurement with technical evaluation by the CFA. The technical committee’s decision is final; brochure delivery goes to OIC GeM (Med), Command Hospital (EC) in Alipore, Kolkata.
The BOQ lists 12 items, including Cinnarizine tablets, Betahistine tablets, Ketorolac eye drops, Xylometazoline nasal drops/solutions, Sulphamethoxazole/Trimethoprim tablets, Gentamicin injections, Amoxicillin suspension, Atropine injections, Diclofenac injections, and Chlorhexidine/Cetrimide solutions; exact quantities not disclosed.
Technical Evaluation Committee decisions are final and binding. Compliance with BBQR, OEM authorizations, shelf-life policy, stock replacement, and past performance will drive evaluation scores; bid rejection possible for missing documents or non-conforming items.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS